A practical reference on visceral adipose tissue: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-03-10. Anything still debated is marked as such rather than presented as settled.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | 44 residues; N-terminal trans-3-hexenoyl group |
| First approval year | 2010 | United States; HIV-associated abdominal fat accumulation |
| Administration route | Subcutaneous injection | Abdominal site; clinician-administered or self-injected |
| Common synonyms | TH9507; tesamorelin acetate | Development code and acetate salt form |
| Originator | Canadian biotechnology firm | Original developer and regulatory sponsor |
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
The peptide is synthesized chemically rather than extracted from biological sources. Solid-phase synthesis builds the chain from the C-terminus toward the N-terminus, after which the hexenoyl group is attached. Purity is typically assessed by high-performance liquid chromatography, and identity is confirmed by mass spectrometry. Regulatory review of the finished product focuses on these analytical controls, since small deviations in sequence or modification can change biological activity. Questions about long-term effects on the pituitary axis remain areas of continued investigation.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone (GHRH) family. Its sequence corresponds to the fully active 44-amino-acid form of human GHRH, with a single structural modification: the addition of a trans-3-hexenoyl group at the N-terminus. That modification is not found in the naturally occurring hormone and was introduced deliberately during development to improve stability against enzymatic degradation. The compound is therefore best described as a stabilized analogue rather than a naturally occurring peptide.
在临床研究之外，特沙莫瑞林常被讨论为生长激素分泌促进剂，但这一说法需要限定。它并不等同于生长激素本身，也不属于普通减重药物。部分研究关注其减少腹部脂肪和改善脂质谱的潜力，另一些研究则关注胰岛素抵抗和 IGF-1 升高等信号。这些效应的临床意义仍在评估中，尚未形成统一结论。
特沙莫瑞林是一种合成肽，其序列与人生长激素释放激素的 44 个氨基酸形式相关。它在 N 端带有反式-3-己烯酰基修饰，这一改动可减缓二肽基肽酶 IV 的降解。该化合物属于生长激素释放激素受体激动剂，可刺激垂体释放生长激素。研究文献通常将其归入合成肽类药物，而非小分子化合物。
Common vervain has been held in high esteem since classical antiquity; it has long been associated with divine and other supernatural forces, and it has an equally long-standing use as a medicinal plant. Herbal capsules are used as a soporific drug in much the same way as for the better known valerian. Verbena officinalis herb has been used in the traditional Austrian medicine internally (as tea or liqueur) for treatment of infections and fever. Medical use of Common Vervain is usually as a herbal tea; Nicholas Culpeper's 1652 The English Physitian discusses folk uses. "Vervain", presumably this species, is one of the original 38 Bach flower remedies, prescribed against "over-enthusiasm". In the modern era, it is sometimes considered a powerful "ally" of poets and writers, as its relaxing effects can relieve writer's block. It cannot be considered safe to use during pregnancy as it might cause miscarriages. While common vervain is not native to North America, it has been introduced there and the Pawnee have adopted it as an entheogen enhancer and in oneiromancy, and is often referred to as the North American version of Calea zacatechichi. In western Eurasia, the term "verbena" or "vervain" usually refers to this, the most widespread and common member of the mostly American genus occurring there. It was called "tears of Isis" in Ancient Egypt, and later on "Juno's tears". In Ancient Greece, it was dedicated to Eos Erigineia.
== Captivity == David Fleay began breeding coastal taipans in 1958, work by Charles Tanner (1911–1996) and him in keeping them in captivity facilitated the production of antivenom. They have proven adaptable to captivity, though they are fast-growing and require food year-round.
On 16 March, Pakistan said that its forces launched multiple airstrikes against Taliban military installations in Kabul and Nangarhar, and claimed that it destroyed ammo storages and "technical support infrastructure". Taliban claimed that Pakistani strikes on Khost province killed four civilians and wounded nine, and destroyed civilian infrastructure in Kunar and Paktika province with 43 rounds being fired into Shkin district. A militant attack on a police post in Bannu District was repulsed by police forces. Following the strikes, Afghanistan claimed that a Pakistani airstrike struck the Omid Addiction Treatment Hospital in Kabul, reportedly killing over 200 people, mostly drug addicts undergoing treatment at the drug rehabilitation facility. Pakistan denied the claims and said that it had only targeted Taliban military installations. While the health ministry spokesperson maintained that there were "more than 200 martyrs and more than 200 injured," deputy government spokesperson Hamdullah Fitrat claimed death toll was at least "double" that, with 250 wounded. Zabihullah Mujahid declared it a "crime against humanity". On 17 March, five Pakistani soldiers were killed and three wounded in a skirmish at Ghulam Khan border crossing in North Waziristan District. A militant attack in Badaber injured two policemen. On 18 March, Pakistani missile strikes in Asadabad wounded six civilians. According to Taliban, Pakistan conducted 63 missile strikes on Nari District, 33 on Manogai, 13 on Sarkani, six on Shultan and six on Asadabad.
The study of human physiology began with Hippocrates in Ancient Greece, around 420 BCE, and with Aristotle (384–322 BCE) who applied critical thinking and emphasis on the relationship between structure and function. Galen (c. 129 – c. 216) was the first to use experiments to probe the body's functions. The term physiology was introduced by the French physician Jean Fernel (1497–1558). In the 17th century, William Harvey (1578–1657) described the circulatory system, pioneering the combination of close observation with careful experiment. In the 19th century, physiological knowledge began to accumulate at a rapid rate with the cell theory of Matthias Schleiden and Theodor Schwann in 1838, that organisms are made up of cells. Claude Bernard (1813–1878) created the concept of the milieu interieur (internal environment), which Walter Cannon (1871–1945) later said was regulated to a steady state in homeostasis. In the 20th century, the physiologists Knut Schmidt-Nielsen and George Bartholomew extended their studies to comparative physiology and ecophysiology. Most recently, evolutionary physiology has become a distinct subdiscipline.
Sources: en.wikipedia.org
In 1982 the film critic Gianni Rondolino created Festival Internazionale Cinema Giovani, which later became the Torino Film Festival. Today Turin is one of the main cinematographic and television centres in Italy, thanks to the role of the Turin Film Commission that reports the production of many feature films, soap operas and commercials. Turin streets were the locations where Audrey Hepburn played War and Peace, Michael Caine drove a Mini Cooper in The Italian Job, Claudio Bisio becomes the president of the Italian Republic, Carlo Verdone set his version of Cinderella, Marco Tullio Giordana shot Piazza Fontana: The Italian Conspiracy, Woody Allen shot Hannah and Her Sisters, Cate Blanchett played Heaven, Giovanna Mezzogiorno Vincere, Marcello Mastroianni and Jacqueline Bisset The Sunday Woman, and Harvey Keitel The Stone Merchant. Turin also became the capital of the tsar for The Demons of St. Petersberg.
In 2007 the British Biochemical Society was given a grant by the Wellcome Trust to catalogue and preserve the 35 laboratory notebooks in which Sanger recorded his research from 1944 to 1983. In reporting this matter, Science noted that Sanger, "the most self-effacing person you could hope to meet", was spending his time gardening at his Cambridgeshire home. Sanger died in his sleep at Addenbrooke's Hospital in Cambridge on 19 November 2013. As noted in his obituary, he had described himself as "just a chap who messed about in a lab", and "academically not brilliant".
=== Surprise cyber attack === The idea of a "cyber Pearl Harbor" has been debated by scholars, drawing an analogy to the historical act of war. Others have used "cyber 9/11" to draw attention to the nontraditional, asymmetric, or irregular aspect of cyber action against a state.
== Modes of delivery == There are three general categories of DNA construct delivery: physical, chemical, and viral. Physical methods, which deliver the DNA by physically penetrating the cell, include microinjection, electroporation, and biolistics. Chemical methods rely on chemical reactions to deliver the DNA and include transformation with cells made competent using calcium phosphate as well as delivery via lipid nanoparticles. Viral methods use a variety of viral vectors to deliver the DNA, including adenovirus, lentivirus, and herpes simplex virus
2024 United States elections 2024 United States gubernatorial elections 2024 United States House of Representatives elections 2024 United States Senate elections Timeline of the 2024 United States presidential election Republican Party efforts to disrupt the 2024 United States presidential election Fundraising in the 2024 United States presidential election
Sources: en.wikipedia.org
It is a laboratory-made peptide of forty-four amino acids whose sequence matches human growth hormone-releasing hormone, with a modified amino terminus. The modification is a short unsaturated fatty acid chain attached to the first residue. This change slows enzymatic breakdown and lengthens the time the peptide stays active in circulation.
The clinical program was designed around HIV-associated lipodystrophy, a condition in which fat accumulates abnormally around the internal organs. Trials enrolled that specific population, so the evidence base covers it rather than the general population. Regulators approved the drug for the studied indication only, and promotion outside it is not permitted.
Growth hormone therapy supplies the finished hormone directly, while this peptide acts upstream and asks the pituitary to secrete its own. That difference means the response depends on a functioning pituitary and on the body's normal feedback loops. It also means the circulating hormone profile is pulsatile rather than a flat, injected level.
It is a synthetic analog of growth hormone-releasing hormone, a hypothalamic peptide. It functions as a growth hormone secretagogue acting at pituitary receptors. The classification separates it from direct growth hormone products.